ZYMFENTRA 120 mg/mL
infliximab-dyyb · INJECTION · CELLTRION USA Inc.
No Recall History
Plain English
ZYMFENTRA is a injection containing infliximab-dyyb at 120 mg/mL, taken subcutaneous. Manufactured by CELLTRION USA Inc..
Key Facts
- Brand Name
- ZYMFENTRA
- Generic Name
- infliximab-dyyb
- NDC Code (Product)
72606-047- Manufacturer
- CELLTRION USA Inc.
- Strength
- 120 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761358
- Marketing Start
- 03/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is ZYMFENTRA used for?
ZYMFENTRA contains infliximab-dyyb. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is ZYMFENTRA a controlled substance?
ZYMFENTRA is not classified as a controlled substance by the DEA.
What is the generic name for ZYMFENTRA?
The generic name for ZYMFENTRA is infliximab-dyyb. There are 1 other brand versions of infliximab-dyyb.
What is the NDC code for ZYMFENTRA 120 mg/mL?
The NDC (National Drug Code) for ZYMFENTRA 120 mg/mL is 72606-047, listed by CELLTRION USA Inc..